tiprankstipranks
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market
Want to see CH:BSLN full AI Analyst Report?

Basilea Pharmaceutica (BSLN) Technical Analysis

7 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is -1.16, suggesting Basilea Pharmaceutica is a Buy.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 52.18, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 53.15, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.

Basilea Pharmaceutica (BSLN) Pivot Points

Jun 08, 2026, 02:01 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
48.63
49.02
49.43
49.82
50.23
50.62
51.03
Fibonacci
49.02
49.32
49.51
49.82
50.12
50.31
50.62
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

Jun 08, 2026, 02:01 PM
Period
Simple
Exponential
MA5
49.84Sell
50.19Sell
MA10
51.42Sell
51.09Sell
MA20
52.90Sell
52.18Sell
MA50
53.59Sell
53.15Sell
MA100
54.02Sell
53.15Sell
MA200
51.38Sell
51.88Sell
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 51.09, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 53.15, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 53.59, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 54.02, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 51.38, creating a Sell signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

Jun 08, 2026, 02:01 PM
Name
Value
Implied Action
RSI (14)
29.14
Buy
STOCH (9,6)
21.05
Neutral
STOCHRSI (14)
16.93
Buy
MACD (12,26)
-1.16
Buy
ADX (14)
23.32
Neutral
Williams %R
-82.81
Buy
CCI (14)
-122.37
Buy
ATR (14)
1.33
-
Ultimate Oscillator
41.97
Neutral
ROC
-9.80
Sell
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 29.14, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 23.32, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is -122.37, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is -9.80, creating a Sell signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Sell.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 29.14, which suggests BSLN is a Buy.
      What is BSLN’s MACD?
      BSLN’s MACD is -1.16, which suggests BSLN is a Buy.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 49.84, which suggests BSLN is a Sell.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 52.90, which suggests BSLN is a Sell.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 53.59, which suggests BSLN is a Sell.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 51.38, which suggests BSLN is a Sell.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -82.81, which suggests BSLN is a Buy.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is -122.37, which suggests BSLN is a Buy.
                    What is the share price of Basilea Pharmaceutica?